Difference between revisions of "MR Coordinating Committee"
Jump to navigation
Jump to search
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
| − | + | Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Caroline Chung, MD; Cathy Elsinger, PhD | |
| − | + | <br />RSNA Staff Support: Susan Stanfa | |
| − | [https:// | + | *[https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true '''Roster'''] |
| Line 14: | Line 14: | ||
==Meetings== | ==Meetings== | ||
| − | * Tcons are held Quarterly. Contact | + | * Tcons are held Quarterly. Contact RSNA Staff for details. |
Revision as of 19:09, 26 January 2021
Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Caroline Chung, MD; Cathy Elsinger, PhD
RSNA Staff Support: Susan Stanfa
Scope
The MR Coordinating Committee coordinates Biomarker Committees based on MR.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the MR Biomarker Committees
Meetings
- Tcons are held Quarterly. Contact RSNA Staff for details.